Microbiome: Accelerating Innovation and Development (MAID) Hub Project



Microbiome bioproducts are rapidly reshaping global health, with applications ranging from cancer therapeutics to next‑generation antimicrobials like bacteriophages, as well as agricultural, nutraceutical and veterinary innovations. Yet despite their potential, innovators still face significant scientific and commercial barriers that slow progress and prevent many microbiome breakthroughs from reaching the market.
MAID is a strategic collaboration led by the University of Liverpool, established to overcome these barriers and unlock the commercial potential of microbiome products, antimicrobial therapies, and diagnostic innovations across the Liverpool City Region (LCR) and throughout the UK. It provides bespoke, end-to-end support to help businesses navigate the complexities of product development, ensuring novel solutions in therapies and diagnostics reach the market faster.
This one-stop-shop is built on the combined expertise of:
- The University of Liverpool’s Microbiome Innovation Centre (MIC): Providing world-class scientific expertise, research capabilities, and access to unique facilities in microbiome science.
- CPI: Leveraging our expertise in scaling up bioprocesses, manufacturing de-risking, and technology commercialisation to bridge the gap between lab-scale innovation and industrial reality.
This project is part of the LCR Life Sciences Innovation Zone Programme* with the aim of supporting organisations in developing their microbiome technology across the UK. The project also underscores the region’s commitment to supporting high-growth SMEs in the life sciences sector.
*The Liverpool City Region Life Sciences Innovation Zone Programme forms part of the Government’s national Investment Zone Programme, positioning the city region as a powerhouse for health and life sciences innovation.

MAID offers targeted support to help innovators progress microbiome and phage‑based innovations, including:
For more details on events, check the Events section below.
Engagement benefits
Working with MAID gives you access to a range of benefits, including:
Technology development
Accelerated translation
Comprehensive end-to-end solutions
Strategic engagement and signposting
Building connections
Funding by LCRCA
Our events include training sessions, in-person workshops, and networking opportunities, bringing together industry to tackle common challenges and build a community of growth within microbiome sciences.
Happening on 26 March 2026, this is a one‑day online training that covers the essential principles of process development for microbiome products. This session will allow the innovators to learn the essential process‑development principles that make technologies scalable, compliant, and ready for manufacturing.
Learn more and register here.
The science is moving fast. The pathways to market are not.Antimicrobial resistance demands bold innovation, but phages, engineered probiotics, recombinant proteins, and vaccines still face major hurdles on the road to real-world impact.
Happening in Liverpool on 6 May 2026, this one-day workshop brings together leaders from across the AMR ecosystem to tackle the practical barriers slowing translation and to define clearer, faster routes to market.
Why attend?
Because innovation without implementation won’t solve AMR.This is where science, regulation, and commercialisation align.
What the day will cover:
- Expanding the AMR therapeutic toolkit.
- Targeted protein and antibody strategies.
- Next-generation microbial therapeutics.
- Vaccines for AMR.
- One health strategies for AMR therapeutics.
Learn more and register here.
We’re committed to supporting innovators progress their technologies, particularly in today’s challenging funding landscape.
Contact us to find out how we can help accelerate your product development journey and move your innovation closer to market.

To find out more about how we can work together, please enter your details below.